Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight for this fee-based midstream company because its financial performance is defined by the interplay of contract-driven revenue stability, cash generation to fund distributions and debt service, and leverage management amid asset transactions.

Composite Trajectory: Mixed

The earnings trajectory is mixed: annual revenue grew 7% to $1.19B in 2025 (10-K 2025-12-31, Consolidated Statements of Operations) but operating income dipped 2% to $644.7M, and Q2 2026 revenue rose 7% to $327.2M while operating income fell 2% to $181.9M and net income fell 9% to $113.5M (10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Cash generation is improving: annual operating cash flow rose 10% to $932.5M in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows) and six-month operating cash flow rose 6% to $492.9M in H1 2026 (10-Q 2026-06-30, Consolidated Statements of Cash Flows). The balance sheet is deteriorating: long-term debt increased 11% to $3.57B and total liabilities rose 13% to $4.42B between Dec 2025 and Jun 2026 while equity declined 1.4% to $1.95B (10-Q 2026-06-30, Condensed Consolidated Balance Sheets), driven by the $1.1B HG Acquisition funded with debt.

2. Red Flags

• Operating income declined 2% YoY in 2025 ($659.2M → $644.7M) despite 7% revenue growth, partly due to an $86.6M loss on long-lived assets from the Utica Shale write-down (10-K 2025-12-31, Consolidated Statements of Operations).
• Q2 2026 net income fell 9% YoY ($124.5M → $113.5M) while revenue rose 7%, with interest expense up 16% to $55.7M (10-Q 2026-06-30, MD&A).
• Long-term debt jumped 11% in six months ($3.22B → $3.57B) and total liabilities rose 13% ($3.91B → $4.42B) to fund the HG Acquisition, while stockholders’ equity fell 1.4% ($1.97B → $1.95B) (10-Q 2026-06-30, Condensed Consolidated Balance Sheets).
• Six-month investing cash flow swung to -$815.8M in H1 2026 from -$72.3M in H1 2025, reflecting $1.1B cash paid for the HG Acquisition partially offset by $379M Utica Divestiture proceeds (10-Q 2026-06-30, Consolidated Statements of Cash Flows).
• Amortization of customer relationships increased to $44.0M in H1 2026 from $35.3M in H1 2025 due to a $549M intangible asset from the HG Acquisition (10-Q 2026-06-30, MD&A).
• The company called for redemption of $650M of 2028 Notes in July 2026, to be funded by cash and Credit Facility borrowings, adding near-term refinancing pressure (10-Q 2026-06-30, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual revenue grew steadily from $1.04B (2023) to $1.11B (2024) to $1.19B (2025) (10-K 2025-12-31, Consolidated Statements of Operations). Annual net income rose from $371.8M to $400.9M to $413.2M over the same periods, but operating income peaked at $659.2M in 2024 then slipped to $644.7M in 2025 due to an $86.6M loss on long-lived assets and higher direct operating expenses. In the most recent comparable quarters, Q2 2026 revenue increased 7% to $327.2M but operating income fell 2% to $181.9M and net income fell 9% to $113.5M (10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Six-month figures show revenue up 8% to $641.5M, operating income up 2% to $370.5M, but net income down 5% to $231.8M, with higher interest expense ($109.7M vs $96.4M) and $9.0M transaction expenses (10-Q 2026-06-30, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow has increased each year: $779.1M (2023) → $844.0M (2024) → $932.5M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). For the six-month periods, operating cash flow rose 6% from $464.1M (H1 2025) to $492.9M (H1 2026) (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Investing cash flow was -$169.2M in 2025 (vs -$242.7M in 2024) but swung to -$815.8M in H1 2026 due to the $1.1B HG Acquisition payment partially offset by $379M Utica Divestiture proceeds (10-Q 2026-06-30, MD&A). Financing cash flow improved from -$601.3M (2024) to -$500.3M (2025) annually, and swung to +$60.0M in H1 2026 from -$391.8M in H1 2025, driven by net Credit Facility borrowings of $437M (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Dividends paid remained steady at ~$439M annually and ~$219M per six-month period.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets grew from $5.76B (Dec 2024) to $5.88B (Dec 2025) to $6.36B (Jun 2026) (10-K 2025-12-31; 10-Q 2026-06-30, Condensed Consolidated Balance Sheets). Long-term debt rose from $3.12B (Dec 2024) to $3.22B (Dec 2025) to $3.57B (Jun 2026). Total liabilities increased from $3.65B to $3.91B to $4.42B over the same dates. Stockholders’ equity declined from $2.12B (Dec 2024) to $1.97B (Dec 2025) to $1.95B (Jun 2026). The six-month change reflects the HG Acquisition: property and equipment rose from $3.45B to $3.94B, customer relationships intangible jumped from $1.07B to $1.65B, and restricted cash/cash equivalents shifted (10-Q 2026-06-30, Condensed Consolidated Balance Sheets). The company remained in compliance with debt covenants as of Dec 2025 and Jun 2026 (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).

6. Data Gaps

• Standalone Q1 2026 quarterly results (only six-month and Q2 2026 are provided in the 10-Q).
• Full-year 2026 results (not yet filed).
• Detailed debt maturity schedule and covenant thresholds (referenced but not quantified in provided excerpts).
• Segment-level cash flow statements (only consolidated cash flows provided).
• Breakdown of 2026 capital expenditures by segment beyond the high-level totals in the 10-Q.
• Realized fee adjustments for 2026 beyond the stated ~1.5% CPI adjustment (10-Q 2026-06-30, MD&A).